Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease - PubMed (original) (raw)
Comparative Study
. 2006 Sep;63(9):1307-11.
doi: 10.1001/archneur.63.9.1307.
Affiliations
- PMID: 16966510
- DOI: 10.1001/archneur.63.9.1307
Comparative Study
Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease
Kiri L Brickell et al. Arch Neurol. 2006 Sep.
Abstract
Background: Genetic influences on the development of late-onset Alzheimer disease (LOAD) are heterogeneous and ill defined.
Objective: To determine the genetic risk factors for LOAD.
Design: We asked the following questions: (1) Does early-onset Alzheimer disease (EOAD) occur in families with predominantly LOAD? and (2) Does the apolipoprotein E (APOE) genotype explain the wide differences in onset age in LOAD families?
Setting: University of Washington Alzheimer Disease Research Center, Seattle.
Participants: A total of 136 kindreds and a separate group of 29 affected parent-child pairs.
Main outcome measures: We evaluated the kindreds with familial LOAD for the occurrence of EOAD and the affected parent-child pairs with a 20-year or more difference in the age at onset.
Results: In the 136 kindreds with LOAD, 104 had only late-onset cases (men, 36%), whereas 32 families (24%) had a combination of LOAD and EOAD cases. The 44 EOAD cases in these families accounted for 20% of cases of AD in the 32 families and 6% in all 136 families. The early-onset cases had a mean +/- SD onset age of 56.1 +/- 3.2 years (range, 45-59 years; men, 50%). Seven (28%) of 25 individuals with EOAD sampled did not have an APOE epsilon4 allele, and 2 of the earliest-onset cases were epsilon3/epsilon3. In 29 parent-child pairs with a 20-year or more difference in age at onset, 7 (35%) of the 20 children sampled did not have an APOE epsilon4 allele.
Conclusions: Many LOAD families (approximately 25%) have at least 1 individual with EOAD, and in these individuals, the ratio of men to women is nearly 50%, suggesting a possible subtype of familial AD. The APOE genotype plays an important role in these early-onset cases, but at least one fourth of the risk must represent the influence of other genetic and/or environmental factors. These LOAD families with early-onset cases represent an important resource for investigation of these factors.
Similar articles
- Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C. van Duijn CM, et al. Nat Genet. 1994 May;7(1):74-8. doi: 10.1038/ng0594-74. Nat Genet. 1994. PMID: 8075646 - Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.
Pérez-Tur J, Campion D, Martinez M, Brice A, Tardieu S, Hannequin D, Agid Y, Delacourte A, Clerget-Darpoux F, Chartier-Harlin MC. Pérez-Tur J, et al. Am J Med Genet. 1995 Dec 18;60(6):550-3. doi: 10.1002/ajmg.1320600613. Am J Med Genet. 1995. PMID: 8825894 - Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.
Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC; Cache County Study Investigators. Khachaturian AS, et al. Arch Gen Psychiatry. 2004 May;61(5):518-24. doi: 10.1001/archpsyc.61.5.518. Arch Gen Psychiatry. 2004. PMID: 15123497 - [Genes in Alzheimer's disease].
Hoenicka J. Hoenicka J. Rev Neurol. 2006 Mar 1-15;42(5):302-5. Rev Neurol. 2006. PMID: 16538594 Review. Spanish. - [Genetic predisposition for Alzheimer's disease].
Staufenbiel M, Pombo-Villar E. Staufenbiel M, et al. Ther Umsch. 1995 Dec;52(12):821-5. Ther Umsch. 1995. PMID: 8539654 Review. German.
Cited by
- Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions.
Tobeh NS, Bruce KD. Tobeh NS, et al. Front Aging Neurosci. 2023 Oct 25;15:1259012. doi: 10.3389/fnagi.2023.1259012. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38020773 Free PMC article. Review. - Dementia-related genetic variants in an Italian population of early-onset Alzheimer's disease.
Bartoletti-Stella A, Tarozzi M, Mengozzi G, Asirelli F, Brancaleoni L, Mometto N, Stanzani-Maserati M, Baiardi S, Linarello S, Spallazzi M, Pantieri R, Ferriani E, Caffarra P, Liguori R, Parchi P, Capellari S. Bartoletti-Stella A, et al. Front Aging Neurosci. 2022 Sep 5;14:969817. doi: 10.3389/fnagi.2022.969817. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36133075 Free PMC article. - Mitochondrial DNA and Alzheimer's disease: a first case-control study of the Tunisian population.
Ben Salem N, Boussetta S, de Rojas I, Moreno-Grau S, Montrreal L, Mokni N, Mahmoud I, Younes S, Daouassi N, Frih-Ayed M, Hammami A, Ben Ammar Elgaaied A, Ruiz A, Cherni L. Ben Salem N, et al. Mol Biol Rep. 2022 Mar;49(3):1687-1700. doi: 10.1007/s11033-021-06978-7. Epub 2021 Dec 1. Mol Biol Rep. 2022. PMID: 34854014 - A meta-analysis of Alzheimer's disease's relationship with human ApoE gene variants.
Xu X, Zhang B, Wang X, Zhang Q, Wu X, Zhang J, Bai Y, Gu X. Xu X, et al. Am J Transl Res. 2021 Sep 15;13(9):9974-9982. eCollection 2021. Am J Transl Res. 2021. PMID: 34650676 Free PMC article. Review. - An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer's Disease.
Vidal C, Zhang L. Vidal C, et al. Cells. 2021 Mar 4;10(3):546. doi: 10.3390/cells10030546. Cells. 2021. PMID: 33806317 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous